International audienceThis article describes the treatment strategies of localized small cell lung cancer. The modalities of pre-therapeutic evaluation, thoracic radiotherapy and prophylactic brain radiotherapy are presented. We discuss also the place of immune checkpoint inhibitor, surgery and thoracic stereotactic radiotherapy. 1877-120
Small cell lung cancer (SCLC) accounts for approximately 20% of all lung cancers. The main treatment...
Lung cancer is the leading cause of cancer deaths worldwide. Small cell lung cancer (SCLC) accounts ...
This study aimed at exploring the multimodality therapy and the role of surgery for small cell lung ...
Cet article décrit la prise en charge des cancers bronchiques à petites cellules de stade localisé. ...
Cet article décrit les avancées récentes relatives à la prise en charge diagnostique et thérapeutiqu...
Small-cell lung cancer (SCLC) accounts for 13% of all lung tumors. The standard treatment in patient...
The fundamental approach to the treatment of small cell lung cancer (SCLC) has not changed in the la...
Introduction or background Small-cell lung cancer (SCLC) represents ~15% of all cases of lung cancer...
These updated clinical practice guidelines on the treatment of small cell lung cancer (SCLC) limited...
Abstract Small‐cell lung cancer (SCLC) is a highly aggressive neuroendocrine tumor that is prone to ...
Purpose: Several sentinel phase III randomized trials have recently been published challenging tradi...
The article discusses the use of irinotecan, cisplatin, and etoposide for the treatment of limited-s...
Of all lung cancers, small cell lung cancer ( SCLS ) occurs with frequency of 25 - 30%. Patient with...
Small cell lung cancer (SCLC), which accounts for about 15% of lung cancer cases, is an aggressive d...
Early stage small cell lung cancer (T1-2N0M0SCLC) represents 7% of all SCLC. The standard treatment ...
Small cell lung cancer (SCLC) accounts for approximately 20% of all lung cancers. The main treatment...
Lung cancer is the leading cause of cancer deaths worldwide. Small cell lung cancer (SCLC) accounts ...
This study aimed at exploring the multimodality therapy and the role of surgery for small cell lung ...
Cet article décrit la prise en charge des cancers bronchiques à petites cellules de stade localisé. ...
Cet article décrit les avancées récentes relatives à la prise en charge diagnostique et thérapeutiqu...
Small-cell lung cancer (SCLC) accounts for 13% of all lung tumors. The standard treatment in patient...
The fundamental approach to the treatment of small cell lung cancer (SCLC) has not changed in the la...
Introduction or background Small-cell lung cancer (SCLC) represents ~15% of all cases of lung cancer...
These updated clinical practice guidelines on the treatment of small cell lung cancer (SCLC) limited...
Abstract Small‐cell lung cancer (SCLC) is a highly aggressive neuroendocrine tumor that is prone to ...
Purpose: Several sentinel phase III randomized trials have recently been published challenging tradi...
The article discusses the use of irinotecan, cisplatin, and etoposide for the treatment of limited-s...
Of all lung cancers, small cell lung cancer ( SCLS ) occurs with frequency of 25 - 30%. Patient with...
Small cell lung cancer (SCLC), which accounts for about 15% of lung cancer cases, is an aggressive d...
Early stage small cell lung cancer (T1-2N0M0SCLC) represents 7% of all SCLC. The standard treatment ...
Small cell lung cancer (SCLC) accounts for approximately 20% of all lung cancers. The main treatment...
Lung cancer is the leading cause of cancer deaths worldwide. Small cell lung cancer (SCLC) accounts ...
This study aimed at exploring the multimodality therapy and the role of surgery for small cell lung ...